Problem:
Each day, about 9 to 10 women in New Zealand are diagnosed with breast cancer, with Māori and Pacific women facing the toughest battles. We want to understand why there are different outcomes for women depending on whether their cancer is detected through screening or by symptoms.
Project:
We’re studying over 40,000 breast cancer cases to analyse detection methods, tumour characteristics, and costs. This will help us make recommendations to improve and expand New Zealand’s breast cancer screening programs.
Outcome:
Our findings could lead to policy changes that make breast cancer detection more affordable, effective, and fair for all women in New Zealand.
Future:
We envision a future where breast cancer detection and treatment are accessible and effective for everyone, helping to improve health outcomes across New Zealand.
Keep reading
View all
From Evidence to Action: Expanding the ‘Not a One-Size-Fits-All’ Breast Cancer Screening Model for Aotearoa New Zealand.
Problem:Breast cancer screening in Aotearoa New Zealand does not benefit all women equally. Many cancers are still found outside the national screening programme, and Māori and Pacific women can fa...
Using Deep Learning And Digital Pathology To Intrinsically Subtype Breast Cancer
Problem:Traditional pathology uses microscopes to examine tissue slides, but this method can be slow and inconsistent, and not all patients can afford advanced molecular testing. Project:Digital pa...
“Shielding” Macrophages: Uncovering Immune-Mediated Chemoresistance in Triple-Negative Breast Cancer
ProblemTriple-negative breast cancer (TNBC) is one of the hardest types to treat and affects Māori and Pacific women more than others. Many patients with TNBC don’t fully respond to chemotherapy, a...
















